Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Study ID
NCT06533813
Status
Recruiting
Apply to this trial

Conditions

  • Myelofibrosis

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

Multicenter retrospective and prospective European observational study. At each site, all consecutive patients with a 2016- or 2022 World Health Organization (WHO) confirmed diagnosis of myelofibrosis (MF) established from 01/01/2018 to 31/12/2027 will be enrolled into the study. Yearly follow-up updates will be scheduled until the end of data collection on 31/12/2028 or until the last available patient visit, whichever comes first. At least 1 year of follow-up will be ensured from the last patient enrolled.

Key Dates

First listed
Aug 1, 2024
Start date
Oct 14, 2024
Status verified
Jul 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
617 participants (estimated)

Primary Outcome Measure

Overall survival according to the presence of cytopenias at diagnosis [ Time Frame: At diagnosis during the baseline ]

Central Contacts

Related Studies